prednisone + somatropin

Prednisone + somatropin is a combination of two pharmaceutical agents used together in certain clinical scenarios. Prednisone is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressive properties, acting primarily as an agonist at the glucocorticoid receptor to modulate gene expression and suppress pro-inflammatory pathways. Somatropin is recombinant human growth hormone (hGH), a peptide hormone that stimulates growth, cell reproduction, and regeneration by binding to the growth hormone receptor. When administered together, somatropin can counteract the protein catabolic effects of prednisone by promoting positive nitrogen balance and increasing whole-body protein synthesis. However, this combination may also increase insulin resistance and glucose intolerance more than either drug alone[1][4]. The efficacy of each agent may be affected when used concomitantly; supraphysiologic doses of glucocorticoids like prednisone can attenuate the growth-promoting effects of somatropin[3][5]. This combination requires careful monitoring due to complex metabolic interactions.